Sonnet biotherapeutics holdings files prospectus relates solely to resale by selling stockholders of up to 29.5 million shares

Sonnet biotherapeutics holdings files prospectus relates solely to resale by selling stockholders of up to 29.5 million shares of common stock.
SONN Ratings Summary
SONN Quant Ranking